Age

19–any

Sex

ALL

Healthy volunteers

Not accepted

Pathologically confirmed ovarian carcinoma
Patients who received "standard treatment" for each stage as a primary treatment
No. of recurrent lesions:
If, all in lung, or intra-abdominal or pelvis organs - ≤ 5 If, any in liver, bone, or spinal cord - ≤ 2
Size of recurrent lesions ≤5 cm
All recurrent lesions are available for involved-field radiotherapy
Within 60 days before enrollment:
Absolute neutrophil count ANC ≥ 500 / mm3
Platelet ≥ 50,000 / mm3
Hb ≥ 8.0 g / dl
Good performance status (ECOG 0-1)

Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer